CBLB and breast cancer: Taken together, our results suggested that Cbl-b negatively regulates the RANKL/RANK pathway in association with the migration of breast cancer cells, and Cbl-b negatively regulates RANK expression by inhibiting p-Src, p-Akt, and p-ERK.